Prehabilitation program for patients with head and neck cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research evaluates the safety and acceptability of a prehabilitation program designed for patients diagnosed with head and neck cancer prior to surgery. The program includes a two-week home-based exercise regimen and nutritional guidance aimed at improving patient outcomes. Participants will be monitored for feasibility and safety through assessments such as the Timed Up and Go (TUG) and 6 Minute Walk Test (6MWT) before and after surgery. The study aims to enroll 20 subjects by August 2025, with each participant's involvement lasting approximately three months.

Why it matters

Who can join: the full rules

Inclusion Criteria:

New head and neck cancer diagnosis Age \> 18

Exclusion Criteria:

1. Prior treatment for head and neck cancer (surgery and/or radiation)
2. Acute or unstable cardiac conditions (unstable angina or symptomatic severe aortic stenosis)
3. American Society of Anesthesiologists physical status of 4 and 5
4. Disabling orthopedic or neuromuscular disease
5. Cardiac failure (New York Heart Association functional classes III and IV)
6. Severe chronic obstructive pulmonary disease
7. End-stage liver or kidney disease
8. Inability to swallow and/or feeding tube dependence
9. Any other comorbid medical, physical, and/or mental condition that contraindicates exercise or oral nutrition
10. Adults unable to consent
11. Age 17.99 or younger
12. Prisoners, pregnant women, or other vulnerable population

Where it's running

• UC Davis Health
  Sacramento, California, United States Recruiting
• UC Davis Medical Center
  Sacramento, California, United States Recruiting

Study contacts

• Principal investigator: Marianne S Abouyared, MD — University of California, Davis
• Study coordinator: Randev Sandhu CRC Supervisor, BS
• Email: rssandhu@ucdavis.edu
• Phone: 9167342863

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Combining chemotherapy and immunotherapy for head and neck cancer treatment

  This study is testing if combining chemotherapy with immunotherapy drugs can help people with head and neck cancer before surgery and possibly reduce the need for radiation therapy afterward.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT04722523

• Tinnitus and Hearing Loss in Head and Neck Cancer Treated with Radiotherapy or Chemoradiotherapy

  This study tests whether tinnitus that starts during treatment is linked to later hearing loss in adults with locally advanced head and neck cancer treated with radiotherapy alone or with chemotherapy.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT05946577

• Using Pembrolizumab with Chemotherapy for Head and Neck Cancer

  This study is testing if combining a blood test that checks tumor DNA with chemotherapy and immunotherapy can help people with head and neck cancer get better results than using immunotherapy alone.

  Recruiting Phase 2 University of Chicago · Chicago, Illinois · NCT05420948

• Mapping neurosensory disorders and pain in patients treated for oral cavity and oropharynx cancer

  This study is trying to understand and track nerve-related issues and pain in patients who have been treated for cancers in the mouth and throat.

  Recruiting University Hospital, Clermont-Ferrand · Clermont-Ferrand · NCT04673981

• Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)

  This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.

  Recruiting Phase 2 Shaukat Khanum Memorial Cancer Hospital & Research Centre · Lahore, Punjab Province · NCT07919444

• Airway ultrasound in head and neck cancer patients

  This observational study tests whether neck ultrasound measurements of the airway match CT measurements in adults with maxillofacial cancer undergoing surgery with anesthesia.

  Recruiting at 2 sites University Hospital Dubrava · Zagreb, City of Zagreb and 1 other locations · NCT07910149

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.